• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. VIVA S; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. VIVA S; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTBB1D1
Device Problems Inappropriate/Inadequate Shock/Stimulation (1574); Invalid Sensing (2293); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Syncope (1610); Abscess (1690); Hematoma (1884); Unspecified Infection (1930); Sepsis (2067); Ventricular Tachycardia (2132); Shock from Patient Lead(s) (3162)
Event Date 12/21/2015
Event Type  Injury  
Manufacturer Narrative
Concomitant product: 1158t lead implanted: (b)(6) 2011.
 
Event Description
It was reported an infection occurred.The implantable cardioverter defibrillator (icd)system was explanted.It was further reported that the patient presented to the emergency department after a syncopal episode and was found to have pseudomonas bacteremia.Drainage of an abscess, a hematoma evacuation and system extraction were performed.The patient had perioperative ventricular tachycardia (vt) which resolved without intervention possibly due to irritation of myocardium and hypotension secondary to sepsis.The patient was treated with antibiotics and a wound vac was placed.The device system was replaced one week later.No further patient complications have been reported as a result of this event.The patient was a participant in the (b)(6) clinical study.
 
Event Description
Additional information received reported the patient was seen in device clinic post implant and had dizziness and swelling/ecchymosis over device site.The patient's medications were changed.The patient was later admitted for a fall and inappropriate therapy was provided as high voltage therapy was given for atrial fibrillation with rapid ventricular response.The bacteremia was then found during hospital stay.A transesophageal echocardiogram noted a thrombus in the left atrial appendage but no lead vegetation was observed.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIVA S
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
anne schilling
8200 coral sea st ne
mounds view, MN 55112
7635052036
MDR Report Key6008025
MDR Text Key56775494
Report Number3004209178-2016-20912
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/18/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/06/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/28/2017
Device Model NumberDTBB1D1
Device Catalogue NumberDTBB1D1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/18/2016
Date Device Manufactured10/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6945-58 LEAD, 694045 LEAD
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age79 YR
Patient Weight67
-
-